Caina Technology Co., Ltd.
301122.SZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.05B
Close$
$-0.12
100.2% downside
Current Fair Value
100.2% downsideOvervalued by 100.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $6.05 Billion |
|---|---|
| Enterprise Value | $5.90 Billion |
| Annual dividend | $0.04 |
| Dividend yield | 0.08% |
| Earnings per Share | $0.05 |
| Beta | 0.8 |
| Outstanding Shares | 122,245,658 |
Return
| Return on Equity | 0.72% |
|---|---|
| Return on Assets | 0.60% |
| Return on Invested Capital | 0.27% |
Valuation & Multiples
| P/E Ratio | 435.48 |
|---|---|
| PEG | -65.83 |
| Price to Sales | 12.74 |
| Price to Book Ratio | 3.4 |
| Enterprise Value to Revenue | 10.7 |
| Enterprise Value to EBIT | 1093.32 |
| Enterprise Value to Net Income | 435 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 28, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$167.59 M
Consensus analyst estimateNext Earnings Call
Expected Date
April 13, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Caina Technology Co., Ltd.
1,057 employees
CEO: Jun Lu
Caina Technology Co., Ltd. is dedicated to the research, development, manufacturing, and distribution of a variety of medical devices, particularly those related to injections and fluid delivery. The company's product portfolio includes ...